Showing results (541-550 of 634) with videos related to
Sort By:
Pageof 64
Asia-Pacific Journal of Clinical Oncology|March 1, 2023
Prospective, open-label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE studyTsai-Sheng Yang, Hong-Hwa Chen, Lin Bo-Wen, et al.International Journal of Radiation Oncology, Biology, Physics|April 22, 2018
Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched AnalysisYoung Seob Shin, Jin-Hong Park, Sang Min Yoon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal CancerFilippo Pietrantonio, Lisa Salvatore, Taito Esaki, et al.Nature Communications|May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancerXueping Qu, Habib Hamidi, Radia M Johnson, et al.Cancer Science|October 13, 2012
Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancerEun Mi Lee, Yong Sang Hong, Kyu-Pyo Kim, et al.The Journal of Biological Chemistry|May 26, 2012
Ring finger protein 149 is an E3 ubiquitin ligase active on wild-type v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)Seung-Woo Hong, Dong-Hoon Jin, Jae-Sik Shin, et al.Asia-Pacific Journal of Clinical Oncology|November 27, 2012
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancerJae-Cheol Jo, Min-Hee Ryu, Dong-Hoe Koo, et al.Experimental & Molecular Medicine|March 3, 2023
Whole-genome sequencing reveals an association between small genomic deletions and an increased risk of developing Parkinson's diseaseJi-Hye Oh, Sungyang Jo, Kye Won Park, et al.Cancer Research and Treatment|September 23, 2009
Optimal timing for the administration of capecitabine with preoperative chemoradiation for locally advanced rectal cancerYoung Ju Noh, Won Sik Choi, Jong Hoon Kim, et al.Annals of Surgical Oncology|August 15, 2015
Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant ChemotherapyJeong Eun Kim, Yong Sang Hong, Hwa Jung Kim, et al.Pageof 64